Compare
Pit 2–4 stocks against each other: U-Score, pillars, fundamentals, and normalized price history. Same universe, same methodology, one view.
| Metric | AHCL Anlon Healthcare Limited Pharma · Small | ANUHPHR Anuh Pharma Limited Pharma · Small | WANBURY Wanbury Limited Pharma · Small | ACCPL Accretion Pharmaceuticals Ltd. Pharma · SME |
|---|---|---|---|---|
| Final Score | 55 | 50 | 64 | 59 |
| Verdict | FAIR VALUE | FAIR VALUE | UNDERVALUED | FAIR VALUE |
| Style | FAIR_VALUE | FAIR_VALUE | Growth at Value | Growth at Value |
| Piotroski | 6/9 | 6/9 | 7/9 | 6/9 |
| Valuation | 10/30 | 16/30 | 16/30 | 18/30 |
| Growth | 21/25 | 12/25 | 21/25 | 19/25 |
| Quality | 11/20 | 2/20 | 18/20 | 16/20 |
| Balance Sheet | 10/15 | 12/15 | 0/15 | 12/15 |
| Cash Flow | 0/10 | 4/10 | 4/10 | 0/10 |
| Price | ₹15.14 | ₹77.55 | ₹265.75 | ₹133.5 |
| P/E | 28.20 | 18.50 | 13.30 | 15.40 |
| P/B | 3.49 | 2.16 | 6.44 | 2.72 |
| ROE | 18.40% | 12.10% | 68.40% | 27.60% |
| ROCE | 20.80% | 15.90% | 30.80% | 28.90% |
| Debt / Equity | 0.19 | 0.00 | 1.54 | 0.23 |
| FCF Yield | — | 1.98% | — | — |
| Dividend Y | — | 1.98% | — | — |
| Altman Z | 5.12 | 4.96 | 3.83 | 6.94 |
| Promoter % | 52.68% | 71.79% | 43.01% | 73.52% |
| Mkt Cap (₹Cr) | 805.00 | 759.00 | 928.00 | 149.00 |
| Graham # | ₹7.25 | ₹56.9 | ₹132.63 | ₹98.14 |
| Fair PE | 42.0 | 42.0 | 42.0 | 42.0 |
| MoS % | +33.2% | +55.0% | +66.6% | +63.5% |
Normalized price (3-year, indexed to 100)
Higher line = better relative performance from startAHCL16
ANUHPHR35
WANBURY102
ACCPL179